- シグナル伝達
- Immunology/Inflammation
- ALCAM/CD166
ALCAM/CD166
Activated Leukocyte Cell Adhesion Molecule
ALCAM (CD166), a cell surface glycoprotein, is a cell adhesion molecule of the immunoglobulin superfamily. ALCAM is expressed by various cell types, such as leukocytes and endothelial cells (ECs). ALCAM can bind to the T cell-expressed scavenger receptor CD6, endothelial L1CAM, and galectin-8. ALCAM regulates diverse pathophysiological processes, including T cell activation, leukocyte trafficking, and angiogenesis. ALCAM is a prognostic marker of cancers. ALCAM promotes tumor growth by controlling cell proliferation, adhesion, migration and invasion[1][2].
All Product Categories
-
ALCAM/CD166 関連製品 (2)
関連製品 (2)
By Targets:
Loading...
Show More (1)
By Effects:
Loading...
By Disease Areas:
Loading...
Show More (2)
ALCAM/CD166 関連製品
関連製品
Clear Filters
-
Praluzatamab
0 Images別名: CX-191; CX-2009 AntibodyPraluzatamab is a monoclonal antibody targeting the activated leukocyte cell adhesion molecule (ALCAM/CD116). Praluzatamab can be used to synthesize Praluzatamab ravtansine (antibody-drug conjugates). Praluzatamab can be used for research of cancers. -
loading...Please select quantityお問い合わせ
August 31
-
Please select quantity
August 31
お問い合わせ
loading... -
-
AT002
0 Images製品番号: HY-P991532別名: MEMD; EJ212/007-Cl2-5 -
loading...Please select quantityお問い合わせ
August 31
-
Please select quantity
August 31
お問い合わせ
loading... -